Skip to main content
Clinical Trials/IRCT20221220056875N1
IRCT20221220056875N1
Completed
Phase 3

Evaluation of the effect of vitamin E in the prevention of acute renal failure in infants weighing more than 1000 admitted to the neonatal intensive care unit

Arak University of Medical Sciences0 sites150 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Arak University of Medical Sciences
Enrollment
150
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Hospitalized in the neonatal intensive care unit
  • Weight more than 1000 grams
  • Not having any congenital or chromosomal abnormalities

Exclusion Criteria

  • Allergy to vitamin E
  • Contraindications for vitamin E use
  • Lack of consent to participate in the study

Outcomes

Primary Outcomes

Not specified

Similar Trials